Dr Sonia Diaz, MD | |
3297 Washington St, Jamaica Plain, MA 02130-2655 | |
(617) 983-6039 | |
(617) 524-1716 |
Full Name | Dr Sonia Diaz |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 3297 Washington St, Jamaica Plain, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396720264 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 208297 (Massachusetts) | Primary |
Entity Name | Massachusetts General Physicians Organization Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Scientists at the Austrlia's, Queensland Institute of Medical Research (QIMR) are currently trialing an experimental "immunotherapy" treatment for men with advanced prostate cancer.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration had granted tentative approval of adenosine injection, USP, the generic equivalent of Astellas Pharmaceuticals' Adenoscan®, in 60 mg per 20 mL and 90 mg per 30 mL vials. IMS data indicate that the 2009 U.S. innovator market for these adenosine presentations approximated $124 million. The Company plans to launch the product upon expiry of applicable innovator patents.
New parents often expect their baby to start sleeping through the night by around six months of age. Indeed, they often receive messages from pediatricians and others about the importance of early sleep consolidation.
An innovative approach to tackling the challenges of pediatric sarcomas is being pursued by researchers at St. Jude Children's Research Hospital (Memphis, Tennessee) with a new grant from Alliance for Cancer Gene Therapy.
› Verified 5 days ago
Entity Name | The General Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Scientists at the Austrlia's, Queensland Institute of Medical Research (QIMR) are currently trialing an experimental "immunotherapy" treatment for men with advanced prostate cancer.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration had granted tentative approval of adenosine injection, USP, the generic equivalent of Astellas Pharmaceuticals' Adenoscan®, in 60 mg per 20 mL and 90 mg per 30 mL vials. IMS data indicate that the 2009 U.S. innovator market for these adenosine presentations approximated $124 million. The Company plans to launch the product upon expiry of applicable innovator patents.
New parents often expect their baby to start sleeping through the night by around six months of age. Indeed, they often receive messages from pediatricians and others about the importance of early sleep consolidation.
An innovative approach to tackling the challenges of pediatric sarcomas is being pursued by researchers at St. Jude Children's Research Hospital (Memphis, Tennessee) with a new grant from Alliance for Cancer Gene Therapy.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Sonia Diaz, MD 56 Laurel Rd, Milton, MA 02186-1539 Ph: (617) 696-2191 | Dr Sonia Diaz, MD 3297 Washington St, Jamaica Plain, MA 02130-2655 Ph: (617) 983-6039 |
News Archive
Scientists at the Austrlia's, Queensland Institute of Medical Research (QIMR) are currently trialing an experimental "immunotherapy" treatment for men with advanced prostate cancer.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration had granted tentative approval of adenosine injection, USP, the generic equivalent of Astellas Pharmaceuticals' Adenoscan®, in 60 mg per 20 mL and 90 mg per 30 mL vials. IMS data indicate that the 2009 U.S. innovator market for these adenosine presentations approximated $124 million. The Company plans to launch the product upon expiry of applicable innovator patents.
New parents often expect their baby to start sleeping through the night by around six months of age. Indeed, they often receive messages from pediatricians and others about the importance of early sleep consolidation.
An innovative approach to tackling the challenges of pediatric sarcomas is being pursued by researchers at St. Jude Children's Research Hospital (Memphis, Tennessee) with a new grant from Alliance for Cancer Gene Therapy.
› Verified 5 days ago
Dr. Staci R Eisenberg, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1153 Centre St, Jamaica Plain, MA 02130 Phone: 617-983-7025 | |
Dr. Kim A Wilson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 75 Bickford St, Martha Eliot Health Center, Jamaica Plain, MA 02130 Phone: 617-971-2312 | |
Wanda Lopez-rodriguez, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3297 Washington Street, Brookside Community Health Center, Jamaica Plain, MA 02130 Phone: 617-522-4700 | |
Dr. Jessica R Roth, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 75 Bickford St, Jamaica Plain, MA 02130 Phone: 617-971-2100 | |
Anne Margaret Welch-cameron, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3297 Washington St, Jamaica Plain, MA 02130 Phone: 617-522-4700 | |
Nuria R Gine-nokes, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3297 Washington Street, Brookside Community Health Center, Jamaica Plain, MA 02130 Phone: 617-522-4700 | |
Alexandra A Epee-bounya, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: Martha Eliot Health Center, 75 Bickford Street, Jamaica Plain, MA 02130 Phone: 617-971-2137 |